Thomas G Fraser

Summary

Affiliation: Cleveland Clinic Foundation
Country: USA

Publications

  1. ncbi Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence
    Abhishek Deshpande
    Cleveland Clinic, Cleveland, OH, USA
    Curr Med Res Opin 24:329-33. 2008
  2. ncbi CLABSI rates in immunocompromised patients: a valuable patient centered outcome?
    Thomas G Fraser
    Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio, USA
    Clin Infect Dis 52:1446-50. 2011
  3. ncbi Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program
    Thomas G Fraser
    Medicine Institute, Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Infect Control Hosp Epidemiol 31:779-83. 2010
  4. ncbi Newer antibiotics for serious gram-positive infections
    Thomas G Fraser
    Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 73:847-53. 2006
  5. ncbi Active tuberculosis in a healthcare worker: are you ready?
    Thomas G Fraser
    Cleveland Clinic Department of Infectious Disease, Quality and Patient Safety Institute, and Occupational Health, Cleveland, Ohio 44195, USA
    Infect Control Hosp Epidemiol 30:80-2. 2009
  6. ncbi Necessary but not sufficient: a comparison of surveillance definitions of Clostridium difficile-associated diarrhea
    Thomas G Fraser
    Cleveland Clinic, Department of Infectious Disease, Cleveland, Ohio 44195, USA
    Infect Control Hosp Epidemiol 30:377-9. 2009
  7. ncbi Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies
    Megan J Digiorgio
    Department of Infection Prevention, Quality and Patient Safety Institute, Cleveland, Ohio, USA
    Infect Control Hosp Epidemiol 33:865-8. 2012
  8. ncbi Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program
    Kimberlee S Fong
    Department of Infectious Disease, Cleveland Clinic, Cleveland, OH 44195, USA
    Chest 142:55-62. 2012
  9. ncbi Endovascular infections caused by Histoplasma capsulatum: a case series and review of the literature
    Christopher Ledtke
    Department of Infectious Diseases, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Arch Pathol Lab Med 136:640-5. 2012
  10. ncbi Cardiac implantable electronic device infections: presentation, management, and patient outcomes
    Khaldoun G Tarakji
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1043-7. 2010

Collaborators

Detail Information

Publications18

  1. ncbi Do fluoroquinolones predispose patients to Clostridium difficile associated disease? A review of the evidence
    Abhishek Deshpande
    Cleveland Clinic, Cleveland, OH, USA
    Curr Med Res Opin 24:329-33. 2008
    ..The data suggesting that fluoroquinolones are an important risk factor for CDAD is becoming stronger. Also, different fluoroquinolones may pose different risks for CDAD development...
  2. ncbi CLABSI rates in immunocompromised patients: a valuable patient centered outcome?
    Thomas G Fraser
    Department of Infectious Disease, Cleveland Clinic, Cleveland, Ohio, USA
    Clin Infect Dis 52:1446-50. 2011
    ..Beyond definitions, IP programs must critically assess the value of their current approach to surveillance to assure that patient-centered outcomes are the focus of prevention efforts...
  3. ncbi Decrease in Staphylococcus aureus colonization and hospital-acquired infection in a medical intensive care unit after institution of an active surveillance and decolonization program
    Thomas G Fraser
    Medicine Institute, Department of Infectious Disease, Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Infect Control Hosp Epidemiol 31:779-83. 2010
    ..To evaluate the effects of an active surveillance program for Staphylococcus aureus linked to a decolonization protocol on the incidence of healthcare-associated infection and new nasal colonization due to S. aureus...
  4. ncbi Newer antibiotics for serious gram-positive infections
    Thomas G Fraser
    Department of Infectious Diseases, Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 73:847-53. 2006
    ....
  5. ncbi Active tuberculosis in a healthcare worker: are you ready?
    Thomas G Fraser
    Cleveland Clinic Department of Infectious Disease, Quality and Patient Safety Institute, and Occupational Health, Cleveland, Ohio 44195, USA
    Infect Control Hosp Epidemiol 30:80-2. 2009
    ..Our experience demonstrates the potential benefits of therapy for latent tuberculosis infection as a component of a tuberculosis-control program...
  6. ncbi Necessary but not sufficient: a comparison of surveillance definitions of Clostridium difficile-associated diarrhea
    Thomas G Fraser
    Cleveland Clinic, Department of Infectious Disease, Cleveland, Ohio 44195, USA
    Infect Control Hosp Epidemiol 30:377-9. 2009
    ..Surveillance definitions mandated by the Ohio Department of Health overrepresented the number of cases attributable to nosocomial transmission at our institution...
  7. ncbi Development of a modified surveillance definition of central line-associated bloodstream infections for patients with hematologic malignancies
    Megan J Digiorgio
    Department of Infection Prevention, Quality and Patient Safety Institute, Cleveland, Ohio, USA
    Infect Control Hosp Epidemiol 33:865-8. 2012
    ..To develop a modified surveillance definition of central line-associated bloodstream infection (mCLABSI) specific for our population of patients with hematologic malignancies to better support ongoing improvement efforts at our hospital...
  8. ncbi Challenges of interferon-γ release assay conversions in serial testing of health-care workers in a TB control program
    Kimberlee S Fong
    Department of Infectious Disease, Cleveland Clinic, Cleveland, OH 44195, USA
    Chest 142:55-62. 2012
    ..Clinical data with use of serial interferon-γ release assay (IGRA) testing in US health-care workers (HCWs) are limited...
  9. ncbi Endovascular infections caused by Histoplasma capsulatum: a case series and review of the literature
    Christopher Ledtke
    Department of Infectious Diseases, Cleveland Clinic, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Arch Pathol Lab Med 136:640-5. 2012
    ..Endovascular infection is an uncommon but devastating manifestation of histoplasmosis, which is often diagnosed late in disease...
  10. ncbi Cardiac implantable electronic device infections: presentation, management, and patient outcomes
    Khaldoun G Tarakji
    Heart and Vascular Institute, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Heart Rhythm 7:1043-7. 2010
    ..Indications for cardiac implantable electronic devices (CIEDs) are increasing. Although CIED infections occur infrequently, the impact of this outcome is expected to be substantial...
  11. ncbi Anti-infective therapy at the end of life: ethical decision-making in hospice-eligible patients
    Paul J Ford
    The Department of Bioethics JJ60, The Cleveland Clinic Foundation, 9500 Euclid Ave, Cleveland, OH 44195, USA
    Bioethics 19:379-92. 2005
    ....
  12. ncbi Outcomes after surgical treatment of native and prosthetic valve infective endocarditis
    Mahesh B Manne
    Department of Internal Medicine, Medicine Institute, The Cleveland Clinic, Cleveland, Ohio 44195, USA
    Ann Thorac Surg 93:489-93. 2012
    ..Recent literature has drawn conflicting conclusions on the benefit of surgery for IE. We reviewed patients treated surgically for IE at the Cleveland Clinic from 2003 to 2007 to examine their outcomes...
  13. ncbi Treatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections
    Elizabeth A Neuner
    Department of Pharmacy, Cleveland Clinic, Cleveland, OH, USA
    Diagn Microbiol Infect Dis 69:357-62. 2011
    ..In summary, CR-Kp bloodstream infections occur in patients who are chronically and acutely ill. They are associated with high 14-day mortality and poor outcomes regardless of tigecycline or other treatment regimens selected...
  14. ncbi The emergence of methicillin-resistant Staphylococcus aureus in the community
    Ravindran A Padmanabhan
    Department of Infectious Diseases, The Cleveland Clinic Foundation, OH 44195, USA
    Cleve Clin J Med 72:235-41. 2005
    ....
  15. ncbi Impact of isolation on hospital consumer assessment of healthcare providers and systems scores: is isolation isolating?
    Joan Vinski
    Quality and Patient Safety Institute, Department of Infection Prevention, Cleveland Clinic, Cleveland, Ohio 44195, USA
    Infect Control Hosp Epidemiol 33:513-6. 2012
    ..Isolated patients reported lower scores for questions regarding physician communication and staff responsiveness. Overall scores for these domains were lower in isolated than in nonisolated patients...
  16. ncbi The use of real-time polymerase chain reaction for rapid diagnosis of skeletal tuberculosis
    Naomi Kobayashi
    Department of Anatomic Pathology, The Cleveland Clinic Foundation, Cleveland, Ohio 44195, USA
    Arch Pathol Lab Med 130:1053-6. 2006
    ....
  17. ncbi Vancomycin and home health care
    Thomas G Fraser
    Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
    Emerg Infect Dis 11:1558-64. 2005
    ..Recommendations for prudent vancomycin use are often overlooked when selecting antimicrobial drugs for home infusion. The public health impact of this practice remains unknown...
  18. ncbi Persistent methicillin-resistant Staphylococcus aureus bacteremia due to a prostatic abscess
    Thomas G Fraser
    Division of Infectious Diseases, Department of Medicine, The Feinberg School of Medicine, Northwestern University, Chicago, Illinois 60611, USA
    Scand J Infect Dis 35:273-4. 2003
    ..The literature describing complications of S. aureus bacteremia and the bacteriology of prostatic abscesses is reviewed. This was found to be the first report of a patient with persistent MRSA bacteremia maintained by a prostatic focus...